Janux Therapeutics Appoints Zachariah McIver, D.O., Ph.D., Vice President, Clinical Development
Janux Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell... | June 5, 2023